Article

Longitudinal investigation for enhancing Down Syndrome Research (LIFE‐DSR) Study: Tau PET and CSF sub‐studies

2021-12-01

Abstract excerpt

Abstract Background The Down syndrome (DS) population is aging rapidly with a life expectancy of nearly 60 years of age compared to 25 years of age in 1980. There are approximately 210,000 people with DS in the USA and about 85,000 are >30 years of age.1 With longevity comes a high risk of Alzheimer’s disease (AD). The lifetime risk of AD is estimated to be >90% ,2 and is the leading cause of death for adults with...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c3da96fc-8109-5cc9-aa53-5086a2de9698
DOI: 10.1002/alz.057426

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Longitudinal investigation for enhancing Down Syndrome Research (LIFE‐DSR) Study: Tau PET and CSF sub‐studiesDOI 10.1002/alz.057426Read

Cross-Sectional Exploration of Plasma Biomarkers of Alzheimer’s Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) StudySemantic proximity Read

The Alzheimer's Biomarker Consortium‐Down Syndrome: Rationale and methodologySemantic proximity Read

Aging with Down Syndrome—Where Are We Now and Where Are We Going?Semantic proximity Read

Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study.Semantic proximity Read

Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndromeSemantic proximity Read

The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discoverySemantic proximity Read

From understanding to action: Exploring molecular connections of Down syndrome to Alzheimer's disease for targeted therapeutic approachSemantic proximity Read

Aging in Down Syndrome and the Development of Alzheimer's Disease NeuropathologySemantic proximity Read

Proteomic analysis of Down syndrome cerebrospinal fluid compared to late-onset and autosomal dominant Alzheimer´s diseaseSemantic proximity Read

Genome-wide association analyses identify candidate loci for amyloid imaging and plasma biomarkers in adults with Down syndrome.Semantic proximity Read

Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional studySemantic proximity Read

Alzheimer's disease in Down syndrome: An overlooked population for prevention trialsSemantic proximity Read